KW:NYSEKennedy-Wilson Holdings Inc. Analysis
Data as of 2026-05-22 - not real-time
$11.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
KW is trading at $11, just above its 20‑day SMA of $10.96 and 50‑day SMA of $10.92, indicating short‑term bullish momentum. The 200‑day SMA sits at $9.64, providing a strong long‑term floor. RSI at 57 and a bullish MACD crossover (+0.0005 histogram) reinforce the upward bias. Volume is rising, and the stock holds above the identified support of $10.87 while facing resistance near $11.09. The Fear & Greed Index reads “Extreme Greed” at 91, suggesting market enthusiasm may be peaking. However, the upside/downside projection is –18%, hinting at limited upside.
On the fundamentals side, revenue slipped 0.8% to $541.5 M, and operating cash flow turned negative at –$24.6 M. The company’s gross margin remains robust at 74.7% and operating margin at 15.5%, yet free cash flow is –$22.4 M. Debt is a major red flag: total debt of $4.85 B translates to a debt‑to‑equity of 312, dwarfing its $189.7 M cash pile. The trailing P/E of 91.7 and forward P/E of –10.3 signal severe overvaluation relative to earnings. Dividend yield appears attractive at 4.36%, but a payout ratio of 400% makes the dividend clearly unsustainable. Combined with a modest ROE of 5% and negative forward EPS, the fundamentals weigh heavily against the technical optimism.
On the fundamentals side, revenue slipped 0.8% to $541.5 M, and operating cash flow turned negative at –$24.6 M. The company’s gross margin remains robust at 74.7% and operating margin at 15.5%, yet free cash flow is –$22.4 M. Debt is a major red flag: total debt of $4.85 B translates to a debt‑to‑equity of 312, dwarfing its $189.7 M cash pile. The trailing P/E of 91.7 and forward P/E of –10.3 signal severe overvaluation relative to earnings. Dividend yield appears attractive at 4.36%, but a payout ratio of 400% makes the dividend clearly unsustainable. Combined with a modest ROE of 5% and negative forward EPS, the fundamentals weigh heavily against the technical optimism.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Technical price near resistance
- High valuation (P/E 91)
- Unsustainable dividend payout
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Debt refinancing risk
- Potential dividend cut
- Support level at $10.87
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Massive leverage
- Negative cash flow
- Overvaluation relative to earnings
Key Metrics & Analysis
Financial Health
Revenue Growth-0.80%
Profit Margin10.93%
P/E Ratio91.7
ROE4.95%
ROA0.83%
Debt/Equity312.16
P/B Ratio2.0
Op. Cash Flow$-24600000
Free Cash Flow$-22425000
Industry P/E32.6
Technical Analysis
TrendBullish
RSI57.4
Support$10.87
Resistance$11.09
MA 20$10.96
MA 50$10.92
MA 200$9.64
MACDBullish
VolumeIncreasing
Fear & Greed Index91.38
Valuation
Target Price$9.00
Upside/Downside-18.18%
GradeOvervalued
TypeValue
Dividend Yield4.36%
Risk Assessment
Beta0.48
Volatility3.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.